Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THOMAS L NICKOLAS

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1558438788
CMS profile
1033937
Location
SAINT LOUIS, MO

General Payments · PY2018–2024

$47,630.30

  • Reported across 36 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$26,153.12

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $13,211.51 4
Consulting Fee $6,903.00 2
Honoraria $5,607.00 1
Food and Beverage $431.61 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Pharmacosmos Therapeutics Inc. $14,074.50 2
Amgen Inc. $12,053.80 11
CALLIDITAS THERAPEUTICS US INC. $24.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $12,859.30 12
PY2019 $32.10 1
PY2020 $41.37 2
PY2021 $4,942.50 2
PY2022 $3,186.00 1
PY2023 $415.91 4
PY2024 $26,153.12 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $106.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 1117641837 CMS
Amgen Inc. $215.18 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1115971330 CMS
Amgen Inc. $4,027.94 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1115971336 CMS
Amgen Inc. $48.90 06/28/2024 Food and Beverage Undisputed 01/23/2026 1115971342 CMS
Amgen Inc. $500.89 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1115971349 CMS
Amgen Inc. $57.12 06/28/2024 Food and Beverage Undisputed 01/23/2026 1115971355 CMS
Amgen Inc. $101.53 06/28/2024 Food and Beverage Undisputed 01/23/2026 1115971361 CMS
Amgen Inc. $3,451.50 08/07/2024 Consulting Fee Undisputed 01/23/2026 1115971367 CMS
Amgen Inc. $3,451.50 08/07/2024 Consulting Fee Undisputed 01/23/2026 1115971371 CMS
Amgen Inc. $49.20 10/25/2024 Food and Beverage Undisputed 01/23/2026 1117641839 CMS
Amgen Inc. $43.30 10/26/2024 Food and Beverage Undisputed 01/23/2026 1115971378 CMS
CALLIDITAS THERAPEUTICS US INC. $24.82 11/07/2024 Food and Beverage Undisputed 01/23/2026 1141526706 CMS
Pharmacosmos Therapeutics Inc. $8,467.50 09/26/2024 Travel and Lodging Undisputed 01/23/2026 1154824683 CMS
Pharmacosmos Therapeutics Inc. $5,607.00 10/15/2024 Honoraria Undisputed 01/23/2026 1154824685 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.